Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)

A Multicenter Observational Study of GammaTile™ Surgically Targeted Radiation Therapy (STaRT) in Intracranial Brain Neoplasms

  • Clinical Trial Information

    Trial Contact: Simoni, Christine; Rodriguez Saavedra, Carlis M; Caldwell, Chloe M

  • IRB No: W22.045.03

    Protocol Abbrev: START-REGISTRY

    Principal Investigator: Catherine E. Mercado, MD

    Age Group: Adult;Pediatric

    Secondary Protocol No: GammaTile Registry, GTM-101

    Treatment: GammaTile-Surgically Targeted Radiation Therapy

    Therapies Involved: Surgery ID: NCT04427384

  • Objective

    The objectives of this registry study are to evaluate real-world clinical outcomes and patient reported outcomes that measure the effectiveness and safety of STaRT.

  • Key Eligibility

    -Ages Eligible for Study: Child, Adult, Older Adult

    -Patients who undergo maximum safe resection of intracranial neoplasm(s) AND implantation of GammaTiles.

    -Willing and able to provide informed consent and to participate in all evaluations.